TABLE 1.
Study | Year | Country | Institution | N = (F/U) |
---|---|---|---|---|
Abe et al.14 | 2000 | Japan | Shiga University of Medical Science, Shiga | 1 (60 months) |
Abe et al.15 | 2010 | Japan | Shiga University of Medical Science, Shiga | 1 (29 months) |
Agarwal et al.16 | 2000 | India | Sanjay Gandhi Postgraduate Institute of Medical Sciences, Lucknow | 1 (5 months) |
Capobianco et al.17 | 2007 | Italy | University of Sassari | 1 (72 months) |
Fayanju et al.29 | 2013 | United States | Siteman Cancer Center, St. Louis | 7 (91 months)a |
Ko et al.18 | 2007 | South Korea | Samsung Medical Center, Seoul | 12 (42 months)a,b |
Lanitis et al.19 | 2009 | United Kingdom | St. Mary’s Hospital, London | 3 (40 months)a |
Lloyd et al.20 | 2001 | United Kingdom | The Royal Marsden Hospital, Sutton | 6 (57 months)a |
Matsuoka et al.21 | 2003 | Japan | The National Shikoku Cancer Center, Matsuyama City | 11 (88 months)a |
Medina-Franco et al.22 | 2002 | United States | University of Alabama, Birmingham | 10 (49 months)a |
Misra et al.23 | 2001 | India | Sanjay Gandhi Postgraduate Institute of Medical Sciences, Lucknow | 4 (13 months)a,c |
Piekarski et al.24 | 2003 | Poland | Medical University of Lodz | 22 (37 months)a |
Steunebrink et al.25 | 2005 | The Netherlands | Albert Schweitzer Hospital, Dordrecht | 1 (42 months) |
Tamiolakis et al.26 | 2008 | Greece | General Hospital of Chania, Crete | 1 (12 months) |
Teodossiu et al.27 | 2009 | Italy | University Hospital, Bari | 1 (48 months) |
Varadarajan et al.28 | 2006 | United States | Roswell Park Cancer Institute, Buffalo | 10 (57 months)d |
F/U time to follow-up
Mean
Follow-up information only available for 2 of 12 patients
Follow-up information only available for 3 of 4 patients
Median